α1-adrenoceptor antagonists.: 5.: Pyridazinone-arylpiperazines.: Probing the influence on affinity and selectivity of both ortho-alkoxy groups at the arylpiperazine moiety and cyclic substituents at the pyridazinone nucleus

被引:37
作者
Betti, L
Floridi, M
Giannaccini, G
Manetti, F
Strappaghetti, G
Tafi, A
Botta, M
机构
[1] Univ Perugia, Ist Chim & Tecnol Farm, I-06123 Perugia, Italy
[2] Univ Pisa, Dipartimento Psichiatria Neurobiol Farmacol & Bio, I-56126 Pisa, Italy
[3] Univ Siena, Dipartimento Farm Chim Tecnol, I-53100 Siena, Italy
关键词
D O I
10.1016/S0960-894X(02)00932-0
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Our previous work on pyridazinone-arylpiperazine derivatives suggested some structural features that a compound should have to show high affinity and good selectivity for alpha(1) adrenoceptors (AR) with respect to alpha(2)-AR. Accordingly, two classes of new alkoxyphenylpiperazinylheptylpyridazinones were designed and synthesized to evaluate the effect of the alkoxy substituent on affinity and selectivity. As expected, affinity increased with larger alkoxy groups. Affinity values are all comparable with that of the reference compound (prazosin), with the exception of compound 1c found 4.5-fold more active than prazosin. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:171 / 173
页数:3
相关论文
共 12 条
[1]   Synthesis, biological evaluation, and pharmacophore generation of new pyridazinone derivatives with affinity toward α1- and α2-adrenoceptors [J].
Barbaro, R ;
Betti, L ;
Botta, M ;
Corelli, F ;
Giannaccini, G ;
Maccari, L ;
Manetti, F ;
Strappaghetti, G ;
Corsano, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (13) :2118-2132
[2]   α1-adrenoceptor antagonists.: 4.: Pharmacophore-based design, synthesis, and biological evaluation of new imidazo-, benzimidazo-, and indoloarylpiperazine derivatives [J].
Betti, L ;
Botta, M ;
Corelli, F ;
Floridi, M ;
Giannaccini, G ;
Maccari, L ;
Manetti, F ;
Strappaghetti, G ;
Tafi, A ;
Corsano, S .
JOURNAL OF MEDICINAL CHEMISTRY, 2002, 45 (17) :3603-3611
[3]  
BETTI L, 2002, Patent No. 000362
[4]   Toward the development of α1a adrenergic receptor antagonists [J].
Bock, MG ;
Patane, MA .
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 35, 2000, 35 :221-230
[5]  
CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
[6]   STUDIES ON QUINAZOLINES .5. 2,3-DIHYDROIMIDAZO[1,2-C]QUINAZOLINE DERIVATIVES - A NOVEL CLASS OF POTENT AND SELECTIVE ALPHA(1)-ADRENOCEPTOR ANTAGONISTS AND ANTIHYPERTENSIVE AGENTS [J].
CHERN, JW ;
TAO, PL ;
YEN, MH ;
LU, GY ;
SHIAU, CY ;
LAI, YJ ;
CHIEN, SL ;
CHAN, CH .
JOURNAL OF MEDICINAL CHEMISTRY, 1993, 36 (15) :2196-2207
[7]   Studies on quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides.: 8.: Synthesis and pharmacological evaluation of tricyclic fused quinazolines and 1,2,4-benzothiadiazine 1,1-dioxides as potential α1-adrenoceptor antagonists [J].
Chern, JW ;
Tao, PL ;
Wang, KC ;
Gutcait, A ;
Liu, SW ;
Yen, MH ;
Chien, SL ;
Rong, JK .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (17) :3128-3141
[8]  
Forray, 1999, Expert Opin Investig Drugs, V8, P2073, DOI 10.1517/13543784.8.12.2073
[9]   Pharmacological options in the treatment of benign prostatic hyperplasia [J].
Kenny, B ;
Ballard, S ;
Blagg, J ;
Fox, D .
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (09) :1293-1315
[10]   ACTIVITY OF AROMATIC SUBSTITUTED PHENYLPIPERAZINES LACKING AFFINITY FOR DOPAMINE BINDING-SITES IN A PRECLINICAL TEST OF ANTIPSYCHOTIC EFFICACY [J].
MARTIN, GE ;
ELGIN, RJ ;
MATHIASEN, JR ;
DAVIS, CB ;
KESSLICK, JM ;
BALDY, WJ ;
SHANK, RP ;
DISTEFANO, DL ;
FEDDE, CL ;
SCOTT, MK .
JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (05) :1052-1056